Base excess and hematocrit predict response to indomethacin in very low birth weight infants with patent ductus arteriosus

BACKGROUND: The treatment of patent ductus arteriosus (PDA) in very low birth weight (VLBW) infants remains a challenge. The ability to predict which infants will respond to indomethacin could spare some from the risks of unnecessary medications. Our objective was to determine if indicators of acid-...

Descripción completa

Detalles Bibliográficos
Autores principales: Mydam, Janardhan, Rastogi, Alok, Naheed, Zahra J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704716/
https://www.ncbi.nlm.nih.gov/pubmed/31439021
http://dx.doi.org/10.1186/s13052-019-0706-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704716/
https://www.ncbi.nlm.nih.gov/pubmed/31439021
http://dx.doi.org/10.1186/s13052-019-0706-y

Ejemplares similares